Safety and Efficacy of a Dietary Supplement in Females With Cellulite

Inclusion Criteria: * Healthy female volunteers * Age between 18 and 45 years at Day 01 of the study * Body mass index (BMI) from 18.5 -24.9 * All Fitzpatrick skin types * CSS score of at least 6 * Normal eating habits (no vegetarians or vegans) * Written informed consent Exclusion Criteria: * Menopause and pre-menopause * Smoking * Pregnant women or women intending to become pregnant during study * Lactation period * Any kind of dermatological conditions * Vegetarians or vegans * Any kind of hepatitis, including any alteration in transaminases * Use of illicit drugs * Other surgical or internal diseases e.g. a metabolic or endocrine disease that may affect the outcome of the study (e.g. diabetes, liver diseases, kidney disorders) or having a history of medical or surgical events that may significantly affect the study outcome including any cardiovascular disease, skin disease, hypertension (\>160/95 mm Hg at repeated measurements) * Existence of scars and/or pigmentation in measurement areas (thighs and buttocks), which can influence study measurements * Participation in any other clinical trial including blood sampling and/or administration or substances up to 30 days before Day 01 of this study * Any prior aesthetic surgery (Liposuction, Subcision®), 3 months before the study, that may interfere with results * Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to the study * Participation in any other non-invasive clinical trial up to 30 days before Day 01 of this study, including blood sampling * Recent blood or plasmapherese donation (less than 1 month prior to Day 01 of the study) * Under medical treatment for a skin disease in the past and/or present with a therapy, which may influence the results of the study (systemic steroids or antibiotics, local steroids or topical immunomodulators during the last 3 months * Use of sun beds or self-tanning products or sun exposure for one month before and during study * Not willing to accept information-transfer concerning participation in the study, or information regarding his/her health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner * Subjects intending to initiate any intensive sports * Every other condition that the investigator might consider to involve a risk for the study subject.